Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - RESEARCH & DEVELOPMENT
Research & Development ALNY - Alnylam Pharmaceuticals, Inc.
1.13 B
LAST VALUE
12.94%
2 YEAR CAGR
11.45%
5 YEAR CAGR
19.46%
10 YEAR CAGR